Apollomics (APLM) Assets Average (2023 - 2025)
Apollomics (APLM) posted quarterly Assets Average of $8.9 million for Q4 2025, down 47.4% year-on-year from $17.0 million in Q4 2024, and down 26.36% on a QoQ basis from $12.1 million in Q2 2025.
Apollomics (APLM) Assets Average (2023 - 2025) Analysis & Trends
Apollomics (APLM) has reported Assets Average for 3 consecutive years, with $8.9 million the latest figure, recorded in Q4 2025.
- Quarterly Assets Average fell 47.4% year-over-year to $8.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.9 million (down 47.4% YoY) and the FY2025 annual result came in at $9.9 million, down 63.54% from the prior year.
- Assets Average fell to $8.9 million in Q4 2025 per APLM's latest filing, from $12.1 million in the prior quarter.
- Over the last five years, Assets Average for APLM reached as high as $73.9 million in Q2 2023 and fell as low as $8.9 million in Q4 2025.
- A 3-year average of $33.2 million and a median of $24.0 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average slumped 69.89% — and 2025, when it sank 47.4%.
- Year by year, Assets Average stood at $56.3 million in 2023, then plunged by 69.89% to $17.0 million in 2024, then slumped by 47.4% to $8.9 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $8.9 million, $12.1 million, and $17.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 8.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.92 Mn |
| Jun 30, 2025 | 12.11 Mn |
| Dec 31, 2024 | 16.95 Mn |
| Jun 30, 2024 | 31.02 Mn |
| Dec 31, 2023 | 56.31 Mn |
| Jun 30, 2023 | 73.93 Mn |